$Ocugen (OCGN.US)$ is at a decent price considering WHO appr...

$Ocugen(OCGN.US)$ is at a decent price considering WHO approving Covaxin and the opportunity for growth from supply and demand. $Pfizer(PFE.US)$ dipped in Dec. 2020 when vaccines were first given so I think Ocugen will followed suit.